Annovis Bio resumes Alzheimer's study delayed by Covid-19 outbreak
October 29, 2020 at 10:37 AM EDT
The company is testing its experimental therapy in patients with early-onset Alzheimer's.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|